Manufacturing and Supply - GSK
WEBWe create innovative manufacturing and supply chain solutions that keeps the world’s health at the forefront. It means we make sure that products are manufactured as efficiently as possible and meet the strictest quality standards.
At a glance | GSK US
WEBAt a glance. Getting Ahead Together means preventing disease as well as treating it. Globally, our portfolio spans vaccines, specialty and general medicines, with R&D focused on science of the immune system, human genetics and advanced technologies.
Locations - GSK
WEBLearn more about GSK around the world by visiting our market websites listed out below. For contact information including product information websites for healthcare professionals, visit our Worldwide directory .
GSK plc - Wikipedia
WEBGSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London.
Company | GSK US
WEBGSK has a significant footprint in the US across commercial, R&D, manufacturing, and corporate functions. We employ ~15,000 people across the US and have two corporate hubs. Explore GSK in the US.
GSK invests $120 million in next-generation US biopharmaceutical ...
WEBSep 25, 2019 · GSK today announced a $120 million investment to expand its manufacturing facility in Upper Merion, Pennsylvania that will support the delivery of the company’s pipeline, bringing new medicines for cancer …
GSK at a glance | GSK
WEBGSK at a glance. We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We prioritise innovation in vaccines and specialty medicines to prevent and treat disease. Download.
How GSK Launched A Continuous Manufacturing Pilot Plant — And …
WEBJul 10, 2017 · This article focuses on GSK’s continuous manufacturing initiatives, the hurdles it faced in bringing the pilot plant online, the lessons it learned from the experience, and what it plans to do next with the technology.
GSK invests $100 million to expand long-term vaccine manufacturing …
WEBGSK today announced $100 million of new investment in its manufacturing site in Hamilton, Montana to expand the production capacity of key components of the adjuvant system used in several of GSK’s vaccines, including SHINGRIX, which was approved by the US Food and Drug Administration in October 2017. …
GSK opens doors at $110M biologics smart factory in UK
WEBJun 21, 2022 · The British Big Pharma has cut the ribbon at its new aseptic smart manufacturing plant in Barnard Castle, England, local news outlet Business Live reported Tuesday. Bankrolled by a £90 million...